OSE Immunotherapeutics Stock Börse Stuttgart
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.124 EUR | +2.36% |
|
-14.61% | -39.50% |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |  |
| 06-10 | OSE Immunotherapeutics SA - Special Call |
| Market Cap | 73.99M 84.39M 68.21M 63.85M 120M 7.96B 122M 820M 317M 3.93B 317M 310M 13.64B | P/E 2026 * |
-2.42x | P/E 2027 * | -2.78x |
|---|---|---|---|---|---|
| Enterprise Value | 114M 130M 105M 98.27M 184M 12.25B 188M 1.26B 488M 6.06B 488M 477M 21B | EV / Sales 2026 * |
18.2x | EV / Sales 2027 * | 12.9x |
| Free-Float |
74.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: OSE Immunotherapeutics
| 1 week | -14.61% | ||
| Current month | -31.45% | ||
| 1 month | -41.48% | ||
| 3 months | -3.60% | ||
| 6 months | -37.07% | ||
| Current year | -39.50% |
| 1 week | 2.99 |  | 3.6 |
| 1 month | 2.99 | | 5.28 |
| 3 years | 2.65 | | 10.74 |
| 5 years | 2.65 | | 13.46 |
| 10 years | 2.65 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Bozec
CEO | Chief Executive Officer | - | 02/10/2025 |
Thomas Gidoin
DFI | Director of Finance/CFO | 43 | 20/08/2025 |
Silvia Comis
CTO | Chief Tech/Sci/R&D Officer | - | 20/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Maryvonne Hiance
BRD | Director/Board Member | 77 | 31/05/2016 |
Brigitte Dreno
BRD | Director/Board Member | 73 | 14/06/2017 |
| Director/Board Member | - | 22/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.36% | -14.61% | -39.38% | -12.30% | 81.67M | |
| -0.48% | +8.75% | -5.51% | +0.91% | 46.36B | |
| +2.19% | +9.81% | +385.81% | +632.13% | 37.88B | |
| +2.53% | +13.90% | +20.85% | -10.61% | 31.12B | |
| +1.65% | +2.98% | +9.98% | +55.42% | 30.61B | |
| -4.16% | -4.44% | +8.53% | +16.06% | 24.69B | |
| -0.32% | +14.36% | - | - | 16.25B | |
| +1.37% | +15.67% | +71.80% | +134.14% | 14.85B | |
| +1.00% | +9.67% | +14.90% | +21.88% | 13.58B | |
| +3.63% | +6.97% | +104.07% | +107.62% | 12.95B | |
| Average | +0.73% | +7.85% | +63.45% | +105.03% | 25.36B | |
| Weighted average by Cap. | +0.59% | +7.66% | +85.50% | +138.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.25M 7.13M 5.76M 5.39M 10.11M 672M 10.32M 69.24M 26.79M 332M 26.77M 26.18M 1.15B | 10.53M 12.01M 9.71M 9.09M 17.04M 1.13B 17.39M 117M 45.14M 560M 45.1M 44.11M 1.94B |
| Net income | -30.59M -34.88M -28.19M -26.39M -49.49M -3.29B -50.52M -339M -131M -1.63B -131M -128M -5.64B | -21.47M -24.48M -19.79M -18.53M -34.74M -2.31B -35.46M -238M -92.03M -1.14B -91.93M -89.93M -3.96B |
| Net Debt | 39.88M 45.49M 36.76M 34.42M 64.54M 4.29B 65.88M 442M 171M 2.12B 171M 167M 7.35B | 62.23M 70.97M 57.36M 53.7M 101M 6.7B 103M 689M 267M 3.31B 267M 261M 11.47B |
| Date | Price | Change |
|---|---|---|
| 26/06/26 | €3.124 | +2.36% |
| 25/06/26 | €3.052 | -4.68% |
| 24/06/26 | €3.202 | -5.27% |
| 23/06/26 | €3.380 | -0.65% |
| 22/06/26 | €3.402 | -2.41% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
Select your edition
All financial news and data tailored to specific country editions
